REGEND-109

肺前体细胞

Report date: 2024/07/29 13:42:22

Base Information

Drug NameREGEND-109
Drug Alias NameREGEND109REGEND-109
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveBronchiectasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesRegend Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRegend Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveBronchiectasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A